myRAteam

Yes, many people have tried Cimzia (Certolizumab pegol) for treating rheumatoid arthritis. Here are some key points from my knowledge base:

- Usage: Cimzia is used to treat adults with moderately to severely active rheumatoid arthritis
- Administration: It is administered as a subcutaneous injection once every two to four Show Full Answer

Yes, many people have tried Cimzia (Certolizumab pegol) for treating rheumatoid arthritis. Here are some key points from my knowledge base:

- Usage: Cimzia is used to treat adults with moderately to severely active rheumatoid arthritis.
- Administration: It is administered as a subcutaneous injection once every two to four weeks.
- Side Effects: Common side effects include upper respiratory tract infections, urinary tract infections, and rash. Rare but serious side effects include severe infections, increased risk for lymphoma and other cancers, heart failure, severe allergic reactions, hepatitis B virus reactivation, nerve damage, low blood cell counts, and lupus-like syndrome.
- Patient Experiences: Some patients have reported success with Cimzia, while others have experienced side effects such as headaches and bronchitis, leading to discontinuation of the drug.

For more detailed information, you can visit the Cimzia website or consult resources like the American College of Rheumatology.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

TNFi Biologics (Humira®, Cimzia®, Enbrel®, Simponi®, Remicade®)

Cimzia (Certolizumab pegol) for Rheumatoid Arthritis | myRAteam